diversified medical healthcareDiversified Medical Healthcare today announced that it has acquired RapidRona and its home wellness testing portfolio.

RapidRona received emergency use authorization in December last year for its SARS-CoV-2 diagnostic test. The home test uses a network of CLIA certified laboratories throughout the U.S. to deliver results to a patient in 48 hours or less.

“We know that Covid-19, unfortunately, is something our population will continue to face,” Diversified Medical Healthcare founder and CEO Kevin Murdock said in a news release. “As recent reports show that the new variants spread faster, cause more severe symptoms, and are causing a decrease in vaccine efficacy, the acquisition of RapidRona is our logical next step in providing necessary solutions for the future of COVID-19. We’re proud to add at-home diagnostic and wellness testing to all that we offer at Diversified Medical Healthcare.”

The RapidRona test kits are designed to provide RT-PCR test results, which is the gold standard of COVID-19 diagnostics to deliver the most accurate results.

“We are excited to see the technology platform in good hands advancing the consumer’s ability to proactively direct their healthcare from home,” RapidRona CEO Heather Mlodinow said.

Diversified Medical Healthcare’s acquisition of RapidRona closed in the second quarter of this year. The financial details of the deal were not disclosed.